Latest News and Press Releases

Oribiotech Ltd. (Ori), announced the launch of its Preferred Partner Network (PPN), bringing together top AMCs and CDMOs.

Clinical trial complexity, logistical challenges associated with treatments, and resource constraints at trial sites cited as top factors that delay enrollment into cell and gene therapy (CGT)...

Ori Biotech announces the appointment of two new members to its senior team and new members to its Strategic Advisory Board (SAB).

Ori Biotech announces the first customer deliveries of the IRO® platform, designed to help address the current challenges in CGT manufacturing.

Ori Biotech and Fresenius Kabi partner to integrate Ori’s IRO® Platform with Cue® and Lovo® systems, advancing scalable cell and gene therapy manufacturing

New York, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Overview According to Dimension Market Research, the Cell and Gene Therapy Market size is expected to reach USD 22.8 billion by 2024 and is further...

Ottawa, Aug. 28, 2024 (GLOBE NEWSWIRE) -- The cell and gene therapy market size is predicted to increase from USD 18.12 billion in 2023 to approximately USD 117.46 billion by 2034. The market is...

A sponsored session will feature Dr. Lucia Gallego Villarejo from Ruhr University Bochum, Dr. Jeanne Loring from Scripps Research Institute, and Dr. Alicia Bertolotti from Bionano presenting on the...

Ori Biotech and CTMC announce promising results for IRO, Ori’s newly launched next-generation CGT manufacturing enabling platform.

Ori Biotech announces the commercial launch of IRO, a next-generation platform built to overcome the challenges of cell therapy manufacturing, at ISCT 2024